Volume 129, Issue 3, Pages (September 2005)

Slides:



Advertisements
Similar presentations
Proinflammatory cytokine–induced and chemical mediator–induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein.
Advertisements

Volume 124, Issue 7, Pages (June 2003)
Volume 114, Issue 5, Pages (May 1998)
Volume 132, Issue 1, Pages (January 2007)
Volume 132, Issue 3, Pages (March 2007)
Volume 130, Issue 1, Pages (January 2006)
Volume 129, Issue 2, Pages (August 2005)
Volume 134, Issue 4, Pages (April 2008)
Volume 126, Issue 2, Pages (February 2004)
Volume 118, Issue 4, Pages (April 2000)
Volume 134, Issue 7, Pages (June 2008)
Volume 129, Issue 3, Pages (September 2005)
Volume 132, Issue 1, Pages (January 2007)
Volume 124, Issue 5, Pages (May 2003)
Characterization of TNF-α– and IL-17A–Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ  Claus Johansen, Trine.
Volume 128, Issue 3, Pages (March 2005)
Volume 69, Issue 4, Pages (February 2006)
Volume 129, Issue 5, Pages (November 2005)
Volume 133, Issue 6, Pages (December 2007)
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Volume 132, Issue 1, Pages (January 2007)
Nod2-Induced Autocrine Interleukin-1 Alters Signaling by ERK and p38 to Differentially Regulate Secretion of Inflammatory Cytokines  Matija Hedl, Clara.
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing.
Volume 136, Issue 5, Pages (May 2009)
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 54, Issue 1, Pages (July 1998)
Α-MSH inhibits TNF-α-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor κB signaling in human chondrosarcoma HTB-94.
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Volume 133, Issue 1, Pages (July 2007)
Volume 120, Issue 7, Pages (June 2001)
Volume 116, Issue 6, Pages (June 1999)
Volume 68, Issue 3, Pages (September 2005)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Volume 119, Issue 3, Pages (September 2000)
Volume 68, Issue 1, Pages (July 2005)
Volume 64, Issue 4, Pages (October 2003)
Volume 120, Issue 5, Pages (April 2001)
Volume 124, Issue 4, Pages (April 2003)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 129, Issue 2, Pages (August 2005)
Volume 127, Issue 5, Pages (November 2004)
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 119, Issue 2, Pages (August 2000)
Volume 63, Issue 2, Pages (February 2003)
Volume 129, Issue 5, Pages (November 2005)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 119, Issue 1, Pages (July 2000)
Histamine Enhances the Production of Granulocyte-Macrophage Colony-Stimulating Factor via Protein Kinase Cα and Extracellular Signal-Regulated Kinase.
Volume 62, Issue 1, Pages (July 2002)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Cyclooxygenase-2 Inhibitor Enhances Whereas Prostaglandin E2Inhibits the Production of Interferon-Induced Protein of 10 kDa in Epidermoid Carcinoma A431 
All-Trans-Retinoic Acid Induces Interleukin-8 via the Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase Pathways in Normal Human Keratinocytes 
Volume 138, Issue 7, Pages e1 (June 2010)
Volume 133, Issue 6, Pages (December 2007)
Volume 61, Issue 6, Pages (June 2002)
Volume 127, Issue 4, Pages (October 2004)
Lori Wilson, Csaba Szabó, Andrew L. Salzman  Gastroenterology 
Volume 126, Issue 4, Pages (April 2004)
Volume 128, Issue 7, Pages (June 2005)
Volume 128, Issue 3, Pages (March 2005)
Volume 114, Issue 6, Pages (June 1998)
Volume 119, Issue 5, Pages (November 2000)
Angiotensin III increases MCP-1 and activates NF-кB and AP-1 in cultured mesangial and mononuclear cells  Marta Ruiz-Ortega, Oscar Lorenzo, Jesus Egido 
Myeloid Differentiation Factor 88 Regulates Basal and UV-Induced Expressions of IL-6 and MMP-1 in Human Epidermal Keratinocytes  Youngae Lee, Hyunjung.
Volume 126, Issue 2, Pages (February 2004)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Hyun Jeong Park, Hee Jung Kim, Jun Young Lee, Baik Kee Cho, Richard L
Volume 126, Issue 5, Pages (May 2004)
The Activity of Caspase-1 Is Increased in Lesional Psoriatic Epidermis
Presentation transcript:

Volume 129, Issue 3, Pages 969-984 (September 2005) Interleukin-22, a Member of the IL-10 Subfamily, Induces Inflammatory Responses in Colonic Subepithelial Myofibroblasts  Akira Andoh, Zhuobin Zhang, Osamu Inatomi, Sanae Fujino, Yasuyuki Deguchi, Yoshio Araki, Tomoyuki Tsujikawa, Katsuyuki Kitoh, Shokei Kim–Mitsuyama, Atsushi Takayanagi, Nobuyoshi Shimizu, Yoshihide Fujiyama  Gastroenterology  Volume 129, Issue 3, Pages 969-984 (September 2005) DOI: 10.1053/j.gastro.2005.06.071 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Immunohistochemical analyses of interleukin (IL)-22 expression in the colon. (A-a) Control normal mucosa (×200), (b) ulcerative colitis (×200), and (c) Crohn’s disease (×200). (B) Dual-colored immunofluorescence was used to determine CD3, CD4, and CD8 expression (FITC, green fluorescence; d, e, or f), IL-22 expression (rhodamine-red, red fluorescence; g, h, and i), and merged (CD3 plus IL-22 [j], CD4 plus IL-22 [k], CD8 plus IL-22 [l], yellow fluorescence). (C) Dual-colored immunofluorescence was used to determine α-smooth muscle actin (α-SMA; FITC, m) and IL-22R1 (rhodamine-red, red fluorescence, n) in normal human colonic mucosa. Double-positive staining can be seen as yellow fluorescence in merged panel (o). Specificity of IL-22R1 immunoreactivity was confirmed by using anti-IL-22R1 antibodies treated with blocking peptide (p). Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Number of IL-22-positive cells in the mucosa. Results were expressed as number of positive cells per field (×400). The lower and upper margins of the box represent the 25th and 75th percentiles, with the extended arms representing the 10th and 90th percentiles, respectively. The median is shown as a horizontal line within the box. Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Effects of IL-22 on [3H]-thymidine incorporation, collagen, and MMP-1 secretion. (A) SEMFs were stimulated for 24 hours, and the [3H]-thymidine incorporation was determined. Each factor was used at 200 ng/mL. Values are expressed as means ± SD (n = 5). **P < .01. (B) SEMFs were incubated with each factor for 24 hours, and collagen secretion was analyzed by SDS-PAGE and Western blotting. (C) SEMFs were stimulated with IL-22 (200 ng/mL) for 24 hours, and secreted MMP-1 levels were determined by ELISA. Values are expressed as mean ± SD (n = 5). **P < .01. (D) SEMFs were stimulated with IL-22 (200 ng/mL) for 24 hours, and secreted MMP-3 was analyzed by Western blotting. Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 (A) Effects of IL-22 on the expression of IL-6, IL-8, IL-11, and LIF mRNA and protein in human colonic subepithelial myofibroblasts (SEMFs). Cells were incubated for 6 hours with 200 ng/mL of IL-22. Total RNA was extracted, and expression of IL-6, IL-8, IL-11, and LIF mRNA was determined by Northern blots. (B and C) Cells were incubated for 24 hours with increasing concentrations of IL-22. The secreted cytokine levels were determined by ELISA. Values are expressed as mean ± SD (n = 5). *P < .05, **P < .01, a significant difference from the values of medium alone. Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 5 (A) RT-PCR analyses for mRNA expressions of IL-10R2 and IL-22R1 in colonic subepithelial myofibroblasts (SEMFs). HT-29 colon cancer cells were used as positive controls. (B) Effects on IL-22 on IL-6 and IL-8 promoter activities. Human IL-6 and IL-8 promoter DNA and β-galactosidase reporter vectors were cotransfected to colonic SEMFs and incubated for 24 hours. Next, cells were incubated with IL-22 (200 ng/mL) for 6 hours. Luciferase activites were measured by the Luciferase Assay System Kit (Promega, Madison, WI) and expressed as relative activities normalized to β-galactosidase activities. Values are expressed as mean ± SD (n = 5). **P < .01, a significant difference from the values of medium alone. (C) Electrophoretic gel mobility shift assays (EMSAs) for NF-κB and AP-1 DNA-binding activities. Cells were incubated with medium alone, IL-22 (200 ng/mL) for 1 hour, and then nuclear extracts were prepared. The dashed arrow indicates nonspecific DNA-protein bound complexes. Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 6 (A) Western blots for IκBα and c-Jun expression. Colonic subepithelial myofibroblasts (SEMFs) were infected with an adenovirus expressing the IκBΔN or DN-c-Jun and then incubated for 48 hours. Expression of IκBα or c-Jun protein was assessed by Western blots. (B) Forty-eight hours after infection with the adenovirus, cells were stimulated with IL-22 (200 ng/mL) for 6 hours. Cytokine mRNA expression was then determined by Northern blots. (C and D) Forty-eight hours after infection with the adenovirus, cells were stimulated with IL-22 (200 ng/mL) for 24 hours, and secreted cytokine levels were determined by ELISA. Values are expressed as mean ± SD (n = 5). *P< .05, **P < .01, a significant difference from the values of IL-22 stimulation. Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 7 MAP-kinase and JAK/STAT activation and the effect of inhibitors on cytokine secretion. (A) Colonic subepithelial myofibroblasts (SEMFs) were stimulated with IL-22 (200 ng/mL), and the activation of MAP kinases and JAK/STAT were evaluated by Western blots. Antibodies directed against phosphorylated (p)- and total-MAP kinase and JAK1/STAT3 were used. (B and C) Cells were pretreated with 20 μmol/L MAP kinase inhibitors (SB203580, PD098059, or U02016) and JAK2 inhibitor (AG490) for 15 minutes. Cells were stimulated with IL-22 (200 ng/mL) for 24 hours, and cytokine levels in supernatants were determined by ELISA. Values are expressed as mean ± SD (n=5). *P < .05, **P < .01, a significant difference from the values of IL-22 stimulation. Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 8 The combined effects from IL-17 and IL-22. (A) EMSAs for NF-κB and AP-1 DNA-binding activities. Cells were incubated for 1 hour with medium alone, IL-22 (200 ng/mL), IL-17 (200 ng/mL), and IL-17 (200 ng/mL) plus IL-22 (200 ng/mL), and nuclear extracts were prepared. (B) Northern blots for cytokine mRNA expression. Cells were stimulated for 6 hours, and total RNA was extracted. (C and D) Cells were stimulated for 24 hours, and secreted cytokine levels were determined by ELISA. Values are expressed as mean ± SD (n = 5). *P < .05, **P < .01, a significant difference from IL-17 stimulation; and +P < .05, ++P < .01, a significant difference from IL-22 stimulation. Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 9 Effects from members of the IL-10 subfamily. (A and B) Colonic subepithelial myofibroblasts (SEMFs) were stimulated for 24 hours with 200 ng/mL of each cytokine, and secreted IL-6, IL-8, IL-11, and LIF levels were determined by ELISA. Values are expressed as mean ± SD (n = 5). *P < .05, **P < .01, a significant difference from the values of medium alone. (C) The combined effects of IL-19 and IL-22. Cells were stimulated for 6 hours with IL-19 (200 ng/mL), IL-22 (200 ng/mL), or IL-19 plus IL-22, and mRNA expression for IL-6, IL-8, and LIF was evaluated by Northern blots. (D) The combined effects of IL-19 and IL-22 on cytokine secretion. Cells were stimulated for 24 hours, and secreted cytokine levels were determined by ELISA. Values are expressed as mean ± SD (n = 5). *P < .05, **P < .01, a significant difference from IL-17 stimulation; and +P < .05, ++P < .01, a significant difference from IL-22 stimulation. Gastroenterology 2005 129, 969-984DOI: (10.1053/j.gastro.2005.06.071) Copyright © 2005 American Gastroenterological Association Terms and Conditions